
Michael A. Riegelman
Examiner (ID: 12379)
| Most Active Art Unit | 3654 |
| Art Unit(s) | 3654 |
| Total Applications | 1332 |
| Issued Applications | 1022 |
| Pending Applications | 97 |
| Abandoned Applications | 247 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18066482
[patent_doc_number] => 20220397569
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => ASSAY FOR RAPID EVALUATION OF CHOROIDAL MAST CELL DEGRANULATION
[patent_app_type] => utility
[patent_app_number] => 17/769960
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11576
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17769960
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/769960 | ASSAY FOR RAPID EVALUATION OF CHOROIDAL MAST CELL DEGRANULATION | Oct 15, 2020 | Pending |
Array
(
[id] => 18019131
[patent_doc_number] => 20220370630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => TRANSMUCOSAL DELIVERY SYSTEM FOR PHARMACEUTICAL ACTIVE INGREDIENT TO SUBMUCOSAL TISSUE OF BLADDER
[patent_app_type] => utility
[patent_app_number] => 17/762279
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762279
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762279 | TRANSMUCOSAL DELIVERY SYSTEM FOR PHARMACEUTICAL ACTIVE INGREDIENT TO SUBMUCOSAL TISSUE OF BLADDER | Oct 1, 2020 | Pending |
Array
(
[id] => 18034739
[patent_doc_number] => 20220378954
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => METHODS FOR RADIOLABELLING GRPR ANTAGONISTS AND THEIR KITS
[patent_app_type] => utility
[patent_app_number] => 17/753850
[patent_app_country] => US
[patent_app_date] => 2020-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12244
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/753850 | METHODS FOR RADIOLABELLING GRPR ANTAGONISTS AND THEIR KITS | Sep 15, 2020 | Pending |
Array
(
[id] => 18075981
[patent_doc_number] => 20220401593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/753762
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753762
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/753762 | STABLE, CONCENTRATED RADIOPHARMACEUTICAL COMPOSITION | Sep 14, 2020 | Pending |
Array
(
[id] => 18434475
[patent_doc_number] => 20230181769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => ANTI-NUCLEOLIN AGENT-PEG-CONJUGATED NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/641787
[patent_app_country] => US
[patent_app_date] => 2020-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8067
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17641787
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/641787 | ANTI-NUCLEOLIN AGENT-PEG-CONJUGATED NANOPARTICLES | Sep 9, 2020 | Pending |
Array
(
[id] => 17831463
[patent_doc_number] => 20220268767
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => NANOPARTICLES FOR DETECTION OF BACTERIA CELLS AND METHODS OF PREPARATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/639469
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9029
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639469 | NANOPARTICLES FOR DETECTION OF BACTERIA CELLS AND METHODS OF PREPARATION THEREOF | Aug 31, 2020 | Pending |
Array
(
[id] => 16555833
[patent_doc_number] => 20210000981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE
[patent_app_type] => utility
[patent_app_number] => 17/007994
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007994
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007994 | CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE | Aug 30, 2020 | Pending |
Array
(
[id] => 20356282
[patent_doc_number] => 12472261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-18
[patent_title] => Conjugated inhibitors of DNA damage response
[patent_app_type] => utility
[patent_app_number] => 17/639234
[patent_app_country] => US
[patent_app_date] => 2020-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 10683
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17639234
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/639234 | Conjugated inhibitors of DNA damage response | Aug 27, 2020 | Issued |
Array
(
[id] => 17988926
[patent_doc_number] => 20220354963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/634897
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -123
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634897
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634897 | EXTRACELLULAR VESICLE LINKED TO MOLECULES AND USES THEREOF | Aug 13, 2020 | Pending |
Array
(
[id] => 17865506
[patent_doc_number] => 20220288241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => LARGE SCALE PRODUCTION OF EXOSOME MIMETICS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/635409
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15202
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17635409
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/635409 | LARGE SCALE PRODUCTION OF EXOSOME MIMETICS AND USES THEREOF | Aug 12, 2020 | Pending |
Array
(
[id] => 18738073
[patent_doc_number] => 20230346986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/625989
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625989
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625989 | METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER | Jul 9, 2020 | Pending |
Array
(
[id] => 17991292
[patent_doc_number] => 20220357329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY
[patent_app_type] => utility
[patent_app_number] => 17/622611
[patent_app_country] => US
[patent_app_date] => 2020-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10545
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622611
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622611 | PREDICTIVE LIQUID MARKERS FOR CANCER IMMUNOTHERAPY | Jun 30, 2020 | Pending |
Array
(
[id] => 19402299
[patent_doc_number] => 20240285810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => DEVELOPMENT OF A NOVEL PET PROBE FOR TARGETED BACTERIAL IMAGING
[patent_app_type] => utility
[patent_app_number] => 17/912167
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6481
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17912167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/912167 | DEVELOPMENT OF A NOVEL PET PROBE FOR TARGETED BACTERIAL IMAGING | Jun 25, 2020 | Pending |
Array
(
[id] => 17792485
[patent_doc_number] => 20220251576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => TRANSFECTION METHOD
[patent_app_type] => utility
[patent_app_number] => 17/622580
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17622580
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/622580 | TRANSFECTION METHOD | Jun 24, 2020 | Pending |
Array
(
[id] => 20686629
[patent_doc_number] => 12616758
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-05-05
[patent_title] => Freeze-dried composition for preparing calibrated gas-filled microvesicles
[patent_app_type] => utility
[patent_app_number] => 17/620170
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7988
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620170 | Freeze-dried composition for preparing calibrated gas-filled microvesicles | Jun 23, 2020 | Issued |
Array
(
[id] => 17895488
[patent_doc_number] => 20220305150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => NOVEL TIN-117M COLLOID FORMULATION WITH THE ABILITY TO DISTINGUISH IT FROM EXISTING TIN-117M COLLOID FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/619921
[patent_app_country] => US
[patent_app_date] => 2020-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17619921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/619921 | NOVEL TIN-117M COLLOID FORMULATION WITH THE ABILITY TO DISTINGUISH IT FROM EXISTING TIN-117M COLLOID FORMULATIONS | Jun 17, 2020 | Abandoned |
Array
(
[id] => 20413085
[patent_doc_number] => 12496348
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-16
[patent_title] => Small molecule target bromo/acetyl proteins and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/617226
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 16053
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617226
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617226 | Small molecule target bromo/acetyl proteins and uses thereof | Jun 16, 2020 | Issued |
Array
(
[id] => 17805991
[patent_doc_number] => 20220257826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHOD OF TREATING LOWER BACK PAIN
[patent_app_type] => utility
[patent_app_number] => 17/617525
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61327
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617525
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617525 | METHOD OF TREATING LOWER BACK PAIN | Jun 11, 2020 | Pending |
Array
(
[id] => 17807437
[patent_doc_number] => 20220259272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => PHOTOACTIVE COMPOSITIONS FOR THERAPUETIC AGENT DELIVERY
[patent_app_type] => utility
[patent_app_number] => 17/618944
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618944
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618944 | PHOTOACTIVE COMPOSITIONS FOR THERAPUETIC AGENT DELIVERY | Jun 11, 2020 | Pending |
Array
(
[id] => 17760101
[patent_doc_number] => 20220233713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => SONODYNAMIC THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/617701
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15886
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617701 | SONODYNAMIC THERAPY | Jun 10, 2020 | Pending |